These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6444094)

  • 1. Antigenic variation and the structure of influenza virus glycoproteins.
    Laver WG
    Microbiol Sci; 1984 May; 1(2):37-43. PubMed ID: 6444094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemistry of variants of influenza virus hemagglutinin and neuraminidase.
    Laver WG
    Adv Exp Med Biol; 1985; 185():149-74. PubMed ID: 3907308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of micropeptide maps and monoclonal antibodies for antigenic variation analysis of influenza A viruses isolated in China from 1972 to 1983.
    Wang ML; Yan JX; Lin QA
    Acta Virol; 1986 Mar; 30(2):97-102. PubMed ID: 2873737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of envelope antigens of influenza A (H3N2) virus isolated during 1983-1985 epidemics and from sporadic cases of infection.
    Stumpa A; Tůmová B; Luther P
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):173-80. PubMed ID: 3411119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The mechanism of antigenic shift and drift of human influenza virus].
    Nakajima K
    Nihon Rinsho; 2003 Nov; 61(11):1897-903. PubMed ID: 14619428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza antigenic determinants are expressed from haemagglutinin genes cloned in Escherichia coli. 1980.
    Emtage JS; Tacon WC; Catlin GH; Jenkins B; Porter AG; Carey NH
    Biotechnology; 1992; 24():491-4. PubMed ID: 1422059
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protective antigen of influenza virus].
    Nobusawa E
    Nihon Rinsho; 1997 Oct; 55(10):2719-24. PubMed ID: 9360397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic and genetic analysis of a recently isolated H1N1 swine influenza virus.
    Olsen CW; McGregor MW; Cooley AJ; Schantz B; Hotze B; Hinshaw VS
    Am J Vet Res; 1993 Oct; 54(10):1630-6. PubMed ID: 8250388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the synonymous and non-synonymous substitution rates in various regions of the neuraminidase and hemagglutinin genes of the influenza A virus].
    Makarova KS; Wulf IuI; Tereza EP; Ratner VA
    Genetika; 1998 Aug; 34(8):1040-4. PubMed ID: 9777350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase.
    Nuss JM; Whitaker PB; Air GM
    Proteins; 1993 Feb; 15(2):121-32. PubMed ID: 7680132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the antigenic and genetic evolution of influenza virus.
    Smith DJ; Lapedes AS; de Jong JC; Bestebroer TM; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    Science; 2004 Jul; 305(5682):371-6. PubMed ID: 15218094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada.
    Abed Y; Hardy I; Li Y; Boivin G
    J Med Virol; 2002 Aug; 67(4):589-95. PubMed ID: 12116009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic peptide of influenza virus hemagglutinin as a model antigen and immunogen.
    Jackson DC; Brown LE
    Pept Res; 1991; 4(3):114-24. PubMed ID: 1823182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
    Johansson BE; Kilbourne ED
    Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of morphological, biological and antigenic properties of avian influenza A virus haemagglutinin H2 in the course of adaptation to new host.
    Lipatov AS; Gitelman AK; Govorkova EA; Smirnov YuA
    Acta Virol; 1995 Dec; 39(5-6):279-81. PubMed ID: 8722298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic variation among equine H 3 N 8 influenza virus hemagglutinins.
    Ozaki H; Shimizu-Nei A; Sugita S; Sugiura T; Imagawa H; Kida H
    Jpn J Vet Res; 2001 Feb; 48(4):177-86. PubMed ID: 11276582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998.
    Bender C; Hall H; Huang J; Klimov A; Cox N; Hay A; Gregory V; Cameron K; Lim W; Subbarao K
    Virology; 1999 Feb; 254(1):115-23. PubMed ID: 9927579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico.
    Horimoto T; Rivera E; Pearson J; Senne D; Krauss S; Kawaoka Y; Webster RG
    Virology; 1995 Oct; 213(1):223-30. PubMed ID: 7483266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on some genetic properties of antigenic recombinants of influenza viruses.
    Podchernyaeva RYa ; Döhner L; Herrmann RM; Blinova VK; Ivanova VT
    Acta Virol; 1982 Jul; 26(4):227-33. PubMed ID: 6127929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.